CoQ10 alleviate preeclampsia symptoms by enhancing the function of mitochondria in the placenta of pregnant rats with preeclampsia.

: To assess whether supplementation with Coenzyme Q10 (CoQ10) during pregnancy alleviate preeclampsia symptoms and the underlying mechanism in the rats with preeclampsia. : Forty-five pregnant Wistar rats were equally divided into three groups randomly and received subcutaneous saline injection (control group, = 15) or 200 mg/kg L-NAME injection to induce preeclampsia symptoms (PE group, = 30). The PE rats were treated by distilled water (PE+DW group, = 15) and CoQ10 (PE+CoQ10 group, = 15) on day 15 to 21 of gestation randomly. Physiological characteristics such as urine volume, total urine protein, blood pressure, number and weight of pups were recorded. Fluorescent dye was used to detect mitochondrial membrane potential in placenta. Real-time fluorescent quantitative PCR was used to detect the expression of mitochondrial DNA(mtDNA) in placenta. : There was no statistic difference among all the three groups on day 10 of gestation in SBP and 24-h proteinuria ( > 0.05). Whereas, SBP and 24-h proteinuria were significantly higher in PE group than control group on day 15 and 21 of gestation ( < 0.05). SBP and 24-h proteinuria were significantly lower in PE+CoQ10 group than PE+DW group on day 21 of gestation ( < 0.05). The number and weight of normal pups were significantly lower in PE group than the control group ( < 0.05), which were most notably in distilled water group, and the number and weight of normal pups were markedly bigger in PE+CoQ10 group rats compared to PE+DW ( < 0.05). The PE+CoQ10 group showed a significantly higher in level of mitochondrial membrane potential than PE+DW group. The expression of mtDNA was significantly higher in the PE+CoQ10 group compared with PE+DW group ( < 0.05). : CoQ10 can alleviate preeclampsia symptoms and enhance the function of mitochondria in the placenta.